Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
Co-founded by Jennifer Doudna and Fyodor Urnov, the company intends to simultaneously develop many gene editing treatments ...
Phenylketonuria (PKU) is a rare genetic condition that affects how your body processes an amino acid called phenylalanine (Phe). People with PKU have low levels or missing activity of an enzyme called ...
Phenylketonuria (PKU) is a rare newborn genetic disease that impacts between 1 in 10,000 to 1 in 20,000 people, depending on the individuals' genetic ancestry. PKU causes an amino acid—called ...
Doha: Sidra Medicine has announced a medical achievement by facilitating access to sepiapterin for patients with Phenylketonuria (PKU), making Qatar ...
Paolo Galfetti, chief operating officer of Relief Therapeutics and chief executive officer of APR Applied Pharma Research SA, shares his family's rare story of living with phenylketonuria GENEVA, ...
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)
CAMBRIDGE, Mass., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that SYNB1934 was granted Rare ...
—Researchers in Germany recently analyzed several parameters related to bone metabolism in plasma, serum, and urine—as well as tracked dietary habits and lifestyle factors—in a cohort of adults with ...
With CRISPR-Cas9 technology making its way toward clinical practice, laboratories are studying different gene-editing techniques, from base editors to prime editors, to correct mutations associated ...
(RTTNews) - Synlogic, Inc. (SYBX), a provider of advancing therapeutics based on synthetic biology, announced Thursday that the U.S. Food and Drug Administration has granted Rare Pediatric Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback